K2 Venture Partners
Beijing, Beijingk2vc.com
Overview
K2 Venture Partners is a venture capital fund managed by the parent firm K2VC (险峰). Founded in 2016, it focuses on early-stage investments in BioTech, MedTech, and life-science companies. The parent firm, K2VC, was founded in 2010 and also manages K2 Angel Partners, which invests in technology and consumer sectors. The firm supports scientists and entrepreneurs in translating innovative technologies into high-impact applications and serves as a long-term partner.
Portfolio Companies
6
Website
k2vc.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sanegene Bio | Dec 2025 | Series B | Co-investor |
| LTZ Therapeutics | Jul 2024 | Series A | Co-investor |
| Aureka Biotechnologies | Mar 2024 | Seed | Lead |
| LTZ Therapeutics | May 2023 | Early Funding | Co-investor |
| Sironax | Aug 2022 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.